Dordaviprone was shown to be effective in these recurrent histone-mutated gliomas, for which we had no other real management options.
...found that 30 percent of patients responded well to the drug.
[
add
]
[
|
|
...
]
Dordaviprone was shown to be effective in these recurrent histone-mutated gliomas, for which we had no other real management options.
...found that 30 percent of patients responded well to the drug.